What does this acquisition mean for humediQ customers?
Varian is committed to the future of the IDENTIFY solutions developed by humediQ and places high value on these products, along with humediQ's expertise, talent and technology.
As a valued humediQ customer, you will continue to experience the advantages of IDENTIFY SGRT technology at your current support level. This acquisition expands the reach of humediQ’s technology by making it more broadly available to the clinical community through Varian’s global marketing and sales channels.
For more specific questions about products, compatibility, distributors, etc., please contact your Varian humediQ representative.
What does this acquisition mean for Varian customers?
Varian has a long history of providing high-quality patient positioning and motion management systems for the treatments it delivers. The acquisition of humediQ’s IDENTIFY technology expands Varian’s patient motion-management portfolio. IDENTIFY includes a state-of-the-art solution for SGRT (Surface Guided Radiation Therapy) and SGRS (Surface Guided Radiosurgery), automated biometric patient identification, and patient setup verification to help ensure safe and effective treatment.
Additionally, Varian and humediQ have similar cultures, values, and a deep commitment to helping treat cancer patients and those fighting to help eradicate the disease around the world.
For more specific questions about products, compatibility, distributors, etc., please contact your Varian representative.